Aspirin may reduce risk of hepatocellular carcinoma

Surgical innovation improves liver cancer treatment

Liver cancer is the most common liver cancer: 60% to 90% of cases are associated with cirrhosis. + read more

Pembrolizumab advances in cholangiocarcinoma

In previously untreated patients, it can prolong survival in combination with chemotherapy without new toxicities. + read more

MD Anderson Cancer Center Madrid, a world leader in oncology

MD Anderson Cancer Center in Houston ranks among the top 300 hospitals worldwide dedicated to cancer care. + read more

Drinking coffee may protect against endometrial cancer risk

Coffee drinking has ‘protective effect’ on endometrial cancer risk. + read more

Risk-model-based lung cancer screening strategy may be more effective than more classical strategies

Future recommendations should consider incorporating individual lung cancer risk models, as suggested by a recent study. + read more

Trends and Challenges of Therapeutic Cancer Vaccines

Vaccines, traditionally considered the best therapy to prevent infectious diseases, are now intending to move it into the field of cancerous tumors. In this sense, a “boom” has been generated by exploring its application, especially in the field of immunotherapy, as a therapeutic alternative to defeat cancer in the near future. + read more